Sequence Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.92 Cr
as on 16-11-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.40 Cr
as on 16-11-2024
- Revenue -14.17%
(FY 2023)
- Profit 1827.14%
(FY 2023)
- Ebitda 8.53%
(FY 2023)
- Net Worth 7.78%
(FY 2023)
- Total Assets -20.01%
(FY 2023)
About Sequence Biotech
The Corporate was formerly known as Sequence Bio-Tech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.92 Cr.
The company currently has active open charges totaling ₹5.40 Cr.
Shrikant Bapat, Vijay Bibikar, Shriram Bhalerao, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2008PTC186895
- Company No.
186895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sequence Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shriram Bhalerao  | Director | 02-Dec-2010 | Current |
| Shrikant Bapat | Director | 02-Dec-2010 | Current |
| Vijay Bibikar | Director | 02-Dec-2010 | Current |
| Rajendra Patil | Director | 19-Sep-2008 | Current |
| Sunita Aghav | Director | 19-Sep-2008 | Current |
Financial Performance and Corporate Structure Insights of Sequence Biotech.
Sequence Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.17% decrease. The company also saw a substantial improvement in profitability, with a 1827.14% increase in profit. The company's net worth moved up by a moderate rise of 7.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequence Biotech?
In 2022, Sequence Biotech had a promoter holding of 34.37% and a public holding of 65.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shrikanchan Hotels And Resorts Private LimitedActive 11 years 4 monthsShrikant Bapat is a mutual person
Labindia Instruments Pvt LtdActive 42 years 4 monthsShrikant Bapat, Vijay Bibikar and 1 more are mutual person
Labindia Analytical Instruments Private LimitedActive 14 years 10 monthsShrikant Bapat, Vijay Bibikar and 1 more are mutual person
Bio-Analytical Technologies (India) Private LimitedActive 21 years 8 daysShrikant Bapat, Vijay Bibikar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 09 Jun 2011 | ₹5.40 Cr | Open |
How Many Employees Work at Sequence Biotech?
Sequence Biotech has a workforce of 11 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequence Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequence Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
